Issue 1/2013
Content (11 Articles)
Tipping the Balance: Benefits and Risks of Aspirin in Chemoprevention of Colorectal Cancer
Prarthana Thiagarajan, Janusz A. Jankowski
Is There Enough Evidence for Aspirin in High-Risk Groups?
Peter C. Elwood, Maribel Almonte, Mohammed Mustafa
Screening for Colorectal Cancer: When, how, and by Whom?
Jochim S. Terhaar sive Droste, Elisabeth Macken, Marc A. Peeters
The Optimal Staging of Rectal Cancer
Ravit Geva, Arye Blachar, Hagit Tulchinsky
Probiotics in the Prevention of Colorectal Cancer
Haim Shmuely, Noam Domniz, Dani Cohen
Prevention and Treatment of Colorectal Cancer by Natural Agents from Mother Nature
Bharat Aggarwal, Sahdeo Prasad, Bokyung Sung, Sunil Krishnan, Sushovan Guha
BRAF, KRAS, and Phosphatidylinositol 3-Kinase in the Management of Metastatic Colorectal Cancer
Anelisa K. Coutinho, Gabriel Prolla, Rui Weschenfelder
Colon Cancer Liver Metastasis: Addition of Antiangiogenesis or EGFR Inhibitors to Chemotherapy
Marcelo R. S. Cruz, Gilberto de Lima Lopes
Newer Agents in Colon Cancer: What’s Next?
Belisario A. Arango, Ikechukwu Akunyili
Blood Biomarkers Linked to Oxidative Stress and Chronic Inflammation for Risk Assessment of Colorectal Neoplasia
Francesca Maffei, Sabrina Angelini, Giorgio Cantelli Forti, Patrizia Hrelia
Intestinal Microbes, Diet, and Colorectal Cancer
Kishore Vipperla, Stephen J. O’Keefe